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Abstract                                                                 ii 
 
The aim of this study was to examine the effect of adding caffeine to a 
carbohydrate electrolyte drink during a modified Loughborough Intermittent 
Shuttle Test (LIST), which incorporates an element of self-pacing (Part B). Ten 
recreationally active (age 21.8 ± 1.5 years, stature 183.9 ± 5.5 cm, mass 86.1 ± 
5.9 kg, estimated VO2max 48.5 ± 3.4 ml/kg·min-1) team sport players performed 
three trials of the modified LIST. Each participant performed the LIST (single 
blind) after ingesting carbohydrate (CHO, 6.4 %) only, caffeine (CAF, 4 
mg/kg/BM) only, or carbohydrate with caffeine (CHO+CAF, 6.4 % + 4 
mg/kg/BM) in a volume of 5 ml/kg/BM one hour prior to testing and 2 ml/kg/BM 
after every 15 minute block. Movement demands and heart rate were measured 
using GPS, with physiological (Countermovement jumps, Blood lactate) and 
perceptual (RPE, gut fullness) measures being taken throughout. Analysis 
indicated no significant differences between trials (P > 0.05) therefore, effect 
sizes (Cohen, 1977) were used to detect possible differences between 
variables. During block 6, participants covered more distance (d = 1.60), 
sprinted faster (d = 0.23), and had a faster average speed (d = 0.48) in the 
CHO+CAF trial as opposed to the CHO trial (P > 0.05). Participants clearly 
engaged in separate pacing profiles throughout both parts of the LIST. Although 
effect sizes indicated some notable differences, it was concluded that the 
addition of CAF to CHO did not provide any significant (P < 0.05) ergogenic 
benefits compared with ingestion of CAF or CHO alone.  
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The effects of carbohydrate and caffeine on self-paced 
intermittent exercise 
 
1. Introduction 
 
Various team games such as basketball, soccer and rugby are 
intermittent in nature, including periods of high intensity exercise (1-7 seconds) 
interspersed with periods of incomplete recovery over an extended period (60-
90 minutes; Bangsbo, 2000; Cunniffe, Proctor, Baker, & Davies, 2009; Spencer, 
Bishop, & Lawrence, 2004). Within these sports, players often perform 
numerous bursts of explosive movements including sprinting, jumping, changing 
direction as well as altering of their pace (Stolen, Chamari, Castagna, & Wisloff, 
2005).  
The average oxygen uptake during intermittent match-play is 
approximately 70% of maximum oxygen uptake (VO2max; Bangsbo, Mohr, & 
Krustrup, 2006). Often, throughout intermittent exercise high intensity efforts are 
repeated over an extended period of time (>90 minutes), and as a result players 
can experience symptoms of neuromuscular fatigue (Jagim, Wright, Brice, & 
Doberstein, 2013). Furthermore, an increased rate of anaerobic glycolysis 
required to maintain such high intensity repeated efforts can increase the 
depletion of muscle glycogen stores (Balsom, Wood, Olsson, & Ekblom, 1999), 
although it would be inappropriate to suggest that a single factor is responsible 
for fatigue during intermittent exercise (Bangsbo, 2000). Exercise induced 
fatigue has also been stated to be caused by an inadequate motor command in 
the motor cortex (Bishop, 2012). Exercise induced fatigue is often seen during 
the final stages of prolonged intermittent exercise, and may be caused by a 
reduced neural activation of the muscle due to impairment of the central 
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nervous system, which can affect mood, motivation, perceptions of effort and 
alertness (Bishop, 2012; Bangsbo, 2000).  
It is potentially due to these causes of fatigue that significant reductions 
in sprint movements have been seen towards the end of team based games 
(Mohr, Krustrup, & Bangsbo, 2003; Bishop, 2012; Waldron, & Highon, 2014). 
For example, the distance covered by soccer players when sprinting was 43 % 
less in the last 15 minutes compared with the first 15 minutes of a match (Mohr 
et al., 2003), reinforcing the point that a player’s ability to perform maximal 
exercise is reduced towards the end of games (Reilly and Thomas, 1976). This 
decline in performance throughout a match could also explain why Armatas et 
al. (2007) found that 32.8 % of goals were scored in the last period of a game 
(76th - 90th min). During exercise, athletes often reduce their work rate in order 
to limit substrate depletion from occurring before the end of an exercise bout 
and thereby increase the likelihood of winning a match (Tucker, 2009; Billaut et 
al., 2011). 
Throughout intermittent exercise, players are required to self-regulate 
their exercise intensity, much like a time trial (Highton, Twist, Lamb, & Nicholas, 
2012). An athlete’s pacing strategy is organised in an anticipatory manner 
designed to optimise performance whilst preventing unreasonably large 
homeostatic disturbances during the exercise bout (Abbiss & Laursen, 2008; De 
Koning et al., 2011). The tendency of athletes to change pace during 
competitive situations is related to both how they rate their perceived exertion 
(rating of perceived exertion; RPE) and how much of the event remains (De 
Koning et al., 2011). An increase in RPE would suggest that working intensity is 
becoming more difficult to maintain, and as a result game players would reduce 
their working intensity (De Koning et al., 2011). RPE has been described as a 
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key mediator in the regulation of work load and could potentially explain how 
exercise intensity is altered to optimise performance and prevent homeostatic 
disruptions (De Koning et al., 2011; Tucker et al., 2009). 
A commonly reported pacing profile in soccer match-play is termed ‘slow-
positive’ whereby there is a gradual decline in total running intensity throughout 
the match (Waldron & Highton, 2014). Pacing profiles of team sports using part-
match players suggest that intensity tends to peak at the start of exercise, 
followed by a reduction in intensity during the middle part of the bout, before 
intensity increases significantly towards the end (Tucker & Noakes, 2009; 
Waldron et al., 2014). This increase in intensity towards the end of match-play 
whereby athletes often use their remaining energy reserves describes the ‘end-
spurt’ phenomenon (De Koning et al., 2011; Waldron et al., 2014).  
Evidence of this was shown by Mohr, Nybo, Grantham, and Racinis, 
(2012) who identified that soccer players’ sprint speeds increased between the 
75th and 90th minute (28.6 km.h-1) compared to speeds obtained between the 
45th and 60th minute (27.7 km.h-1 ). They also sprinted further in the last 15 
minute interval (21.8 m) as opposed to between the 45th and 60th minute (20.4 
m). 
In soccer, the demands of match play have been analysed, and as a 
result protocols have been designed in an attempt to replicate these demands 
(Drust, Reilly, & Cable, 2000). The Loughborough Intermittent Shuttle Test 
(LIST) is a protocol that accurately simulates the activity patterns during a game 
of soccer (Nicholas, Nuttall & Williams, 2000). Modified versions of the LIST 
have been produced to include elements of self-pacing in order to investigate 
effects of pacing strategies within intermittent team sports (Highton et al., 2012). 
This modified LIST incorporating self-paced exercise has previously been 
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shown to possess a coefficient of variation of 1.7 and 5.4 % for distance 
covered and sprint performance (Ali, Gant, Foskett, Moss, & Lynch, 2009). 
Protocols that do not closely replicate the demands of match play should not be 
used for measurements of acute interventions such as nutritional supplements 
(Currell & Jeukendrup, 2008) 
Considerable attention has focused on nutritional strategies to maximise 
carbohydrate stores, thereby minimising the potential effects of carbohydrate 
depletion (Bangsbo et al., 2006; Coyle, Coggan, Hemmert, & Ivy, 1986). As 
carbohydrate is the primary fuel source for high intensity intermittent exercise, 
inadequate muscle glycogen stores will limit the performance of repeated high 
intensity exercise bouts (Castell, Burke, Stear, & Maughan, 2010).  
The influence of ingesting carbohydrate-electrolyte solutions immediately 
prior to and during prolonged intermittent, high intensity exercise designed to 
replicate field-based team games is becoming more common (Phillips, Sproule, 
& Turner, 2011). Ingesting carbohydrate has the potential to delay central and 
peripheral fatigue, improve match performance and aid rehydration especially 
towards the end of a game (Davis & Brown, 2001; Jentjens & Jeukendrup, 
2003; Jeukendrup, 2014).  
Goedecke et al. (2013) investigated the effects of carbohydrate ingestion 
versus a placebo on exercise performance during a simulated soccer match 
protocol. The ingestion of a 7 % carbohydrate solution improved time to fatigue 
suggesting an improved performance in the latter stages of a game. However, 
in this study the protocol focused on time to fatigue which is not specific to the 
nature of intermittent team sport players.  
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Similarly, Ali, Williams, Nicholas and Foskett, (2007) investigated the 
effects of carbohydrate ingestion on performance during the LIST. 16 male 
soccer players ingested either a 6.4 % carbohydrate electrolyte (CHO-E) 
solution or a placebo (PLA) solution before (5 ml/kg/BM) and during (2 
ml/kg/BM) the LIST. Sprint performance (CHO-E= 2.50 ± 0.13 vs PLA= 2.53 ± 
0.13 s) was significantly better maintained in the carbohydrate trial suggesting 
the importance of carbohydrate as a fuel source for maintaining glycogen levels 
in intermittent team sport players.  
In addition to carbohydrate supplementation, research has focused on 
caffeine (a trimethylxanthine) supplementation to reduce feelings of pain and 
fatigue acting on the central nervous system (CNS), potentially increasing 
cognitive and endurance performance and enhancing lipolysis, decreasing the 
reliance on glycogen utilisation (Tarnopolski, 2008; Goldstein et al., 2010; 
Armstrong, Casa, Maresh, & Ganio, 2007; Stear et al., 2010; Plaskett & 
Cafarelli, 2001). Just like carbohydrate supplementation, caffeine 
supplementation has been described as an effective ergogenic aid for 
prolonged high-intensity exercise such as intermittent team sports (Goldstein et 
al., 2010).  
Caffeine is often used as an aid to sports performance and is now 
appearing in many new products including sports drinks (Castell et al., 2010; 
Graham, 2001). It appears to exert positive effects on exercise capacity over a 
diverse range of protocols including prolonged submaximal exercise (Stear, 
Castell, Burke, & Spriet, 2010).  
Stuart, Hopkins, Cook and Cairns (2005) investigated the effects of 
caffeine on simulated high-intensity team sport performance. Nine male rugby 
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players ingested either caffeine (6 mg/kg/BM) or a placebo (dextrose) 70 
minutes before a rugby specific simulation protocol. The ingestion of caffeine as 
opposed to a placebo improved 30 m sprint speed (+ 2.3 %), and reduced 
fatigue by 10 % during the passing accuracy test, suggesting an improved 
performance in the latter stages of a game.  
Despite previous established research focusing upon the separate 
ergogenic effects of caffeine (Stear et al., 2010; Plaskett et al., 2001; Stuart et 
al., 2005) and carbohydrate (Goedecke et al., 2013; Ali et al., 2007), very few 
studies have investigated the effect of combined carbohydrate and caffeine 
intake on intermittent exercise performance (Hulston & Jeukendrup, 2008), and 
therefore, this area requires more sport specific research (Roberts et al., 2010). 
One study which has was conducted by Roberts et al., (2010). Eight 
male rugby union forwards ingested either a placebo or carbohydrate before 
and during a rugby union specific protocol, with pre-exercise caffeine ingestion 
(4 mg/kg/BM) before one of the carbohydrate trials (3 trials). 15 m sprints were 
performed faster and perceived exertion (RPE) was significantly lower (P = 
0.020) in the carbohydrate with caffeine trial (13.5 ± 1.3) compared with 
carbohydrate (14.4 ± 1.5) or placebo (14.8 ± 2.0), reinforcing its proposed 
benefits of attenuating mental fatigue and reducing feelings of exertion.  
Gant, Ali, and Foskett, (2010) investigated the effects of combined 
carbohydrate and caffeine co-ingestion on performance during the LIST. The 
addition of caffeine to a carbohydrate solution improved sprinting performance 
and counter-movement jumping suggesting that caffeine facilitated a reduced 
decline in exercise induced fatigue. However, the participants completed 6 x 15 
m blocks of the LIST and therefore the protocol did not incorporate any form of 
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self-pacing which has previously been identified as an important notion affecting 
intermittent team sport performance.  
Accordingly, the aim of this study is to investigate the effects of adding 
caffeine to a carbohydrate solution before a modified LIST which incorporates 
an element of self-pacing. Part A (prescribed) of the LIST acts as a fatiguing 
pre-load whereas part B (self-paced) is suggested to act as a performance test, 
resulting in an ecologically valid performance protocol (Ali et al., 2014). 
From the present research it can be hypothesised that as a result of the 
potential benefits of combined carbohydrate and caffeine supplements, 
throughout the LIST, physiological performance will be better and reports of 
exertion (RPE) will be lower compared with the supplements alone. It is also 
hypothesised that, as a result of sparing glycogen levels following carbohydrate 
ingestion, and reduced feelings of exertion following caffeine ingestion, 
participants will be able to perform noticeably better during self-paced exercise 
(block 6).  
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2. Methods 
2.1. Participants and Design 
Ten recreationally active (age 21.8 ± 1.5 years, stature 183.9 ± 5.5 cm, 
mass 86.1 ± 5.9 kg, estimated VO2max 48.5 ± 3.4 ml/kg·min-1) team sport 
players (rugby union, n = 4; soccer, n = 3; basketball, n = 3) volunteered to 
participate in this study. After receiving an oral and written explanation of the 
study (appendix 1), all participants provided their written informed consent 
(appendix 2) and completed a pre-test health questionnaire (appendix 3). 
Participants were required to complete a food diary on the day prior to testing 
(appendix 4) which was replicated before each weekly trial, as well as perform 
an overnight fast from midnight the night before testing. Approval for this study 
was obtained from the ethics committee of the Faculty of Life Sciences, 
University of Chester (appendix 6).   
A single-blind, repeated measures design was implemented in this study, 
in which participants completed 3 trials in a random order separated by 7-10 
days. The three trials were carbohydrate only (CHO), caffeine only (CAF) and 
carbohydrate with caffeine (CHO + CAF). Each participant was required for a 4 
week testing schedule (Figure 2.1), in which they were tested at the same time 
on approximately the same day on a weekly basis. They were asked to refrain 
from strenuous exercise for 24 hours prior to each trial whilst continuing with 
their normal diet and training regime up to the day prior to testing, on which diet 
was recorded and replicated. Participants were provided with a list of items 
which contained amounts of caffeine and asked to avoid these substances in 
the 48 hours prior to each testing visit (appendix 5). 
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Figure 2.1. Four week testing schedule 
 
 
 
 
 
 
 
 
 
Figure 2.2. Schematic of the study design 
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2.2. Procedures 
2.2.1. Baseline Measurements 
Following a standardised warm up, participants completed the Multi-
Stage Shuttle Run Test (MSSRT; Ramsbottom, Brewer, & Williams, 1988) on 
an indoor wooden surface (University gymnasium) to obtain an estimate of 
aerobic capacity (VO2max). The MSSRT consists of shuttle running between two 
markers placed 20 m apart at increasing running speeds (0.14 ms-1) until 
exhaustion. From this estimate of VO2max, running (95% of VO2max) and jogging 
(55% of VO2max) speeds were calculated for the LIST. Following this, 
participants performed two cycles of part A and two cycles of part B to 
familiarise themselves with the modified LIST.  
2.2.2. The Modified - Loughborough Intermittent Shuttle Test (LIST) 
Soccer match-play was simulated using the modified LIST (Figure 2.2). 
The test was completed on an outdoor AstroTurf pitch and all participants were 
asked to wear AstroTurf trainers for all 3 visits. During the modified LIST, 
participants ran alone completing four 15 minute blocks of a set pattern of 
exercise for 60 minutes (Part A) followed by two 15 minute blocks of self-paced 
exercise (Part B). Running and walking speeds were dictated by an audio CD 
throughout part A of the test. In part B, participants were asked to replicate the 
set pattern of exercise as best they could although without the audio CD. The 
LIST protocol, incorporating an element of self-pacing has been deemed a 
reliable test for measuring performance in intermittent team sports (Ali, Foskett, 
& Gant, 2014). Environmental temperature and humidity were both recorded 
throughout each testing visit (THG810, Oregon Scientific Ltd., Berkshire, UK). 
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2.2.3. Supplementation 
Participants ingested one of three beverages, both before and during the 
LIST. All drinks, which were made on the day of testing, were issued in an 
opaque 1 litre bottle. All supplements were weighed out accurately and checked 
by a laboratory technician.  
In the CHO trial participants were given a 6.4 % CHO solution (Lucozade 
Sport, GlaxoSmithKline, Brentford, U.K) in a volume of 5 ml/kg/BM one hour 
prior to exercise and 2 ml/kg/BM after every 15 minute block. This 
supplementation regimen was adopted from a combination of previous research 
utilising nutritional strategies during the LIST (Ali et al., 2007; Gant, Ali, & 
Foskett., 2010; Highton et al., 2012; Nicholas, Tsintzas, Boobis, & Williams., 
1999). Mean ingestion was 430.5 ± 29.5 ml of CHO solution prior to testing and 
172.2 ± 11.9 ml after every 15 minutes. This resulted in 32.4 ± 2.2 g of CHO 
being ingested one hour before testing and 12.9 ± 0.8 g being ingested after 
every 15 minutes. Over the first hour of exercise participants ingested 51.7 ± 
3.2 g of CHO, which is within the guidelines of 30-60 g/h reported by Convertino 
et al., (1996).  
In the CAF trial, participants ingested 4 mg/kg/BM of CAF in a powder 
form (Myprotein, Northwich, UK) mixed with an artificially sweetened orange 
flavoured non-carbohydrate solution in an amount relative to 5 ml/kg/BM. The 
CAF mixed with the non-CHO solution was ingested 1 hour before exercise due 
to previous research identifying that optimal absorption occurs after 1 hour of 
ingestion (Goldstein et al., 2010). Every 15 minutes during the modified LIST 
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they ingested just the artificially sweetened orange flavoured non-carbohydrate 
solution in an amount relative to 2 ml/kg/BM 
In the CHO + CAF condition, the same 6.4 % CHO solution was ingested 
in a volume of 5ml/kg/BM before exercise mixed with 4 mg/kg/BM of CAF. After 
every 15 minute block just the CHO solution was ingested in a volume relating 
to 2 ml/kg/BM. 
2.2.4. Movement demands and heart rate  
During the LIST participants wore a portable GPS unit (5 Hz; SPI-Pro, 
GPSports, Canberra, Australia) which was placed between the scapular in a 
sports vest. In addition to this, a compatible heart rate monitor (Polar Electro 
Oy, Kempele, Finland) was tightly fitted around the participant’s chest.  
Total distance covered (m), average speed (km.h-1), average heart rate (bpm), 
and peak speeds (km.h-1) for each block of each trial were collected. The 
coefficient of variation for distance covered and running speed when using this 
GPS unit is reported to be 1.8 and 1.7 % (Highton et al., 2012). Furthermore, 
average walk, jog, cruise and sprint speeds (km.h-1) were calculated from block 
6 (self-paced). All GPS data was downloaded and analysed using Team AMS v 
2.1 (GPSports, Canberra, Australia). 
2.2.5. Neuromuscular function 
Neuromuscular function was assessed using the counter-movement 
jump (CMJ) which required participants to adopt an upright position, and then 
on instruction from the researcher, flex their knees to 90 degrees and then jump 
vertically for maximal height onto a jump mat. Participants were instructed to 
keep their hands on their hips at all times and maintain a fully extended leg 
position during the jump and on landing. CMJ has been identified as a reliable 
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and valid measure (Markovic, Dizdar, Jukic, & Cardinale, 2004) and were 
recorded before and during the LIST (Figure 2.2) using a CMJ mat. (Probotics 
Inc, Huntsville, USA). Flight time (s) was used for data analysis. 
2.2.6. Perceptual measures 
Participant’s RPE and gut fullness were measured after each 15 minute 
block of the LIST (Figure 2.2) using the Borg 6-20 scale (Borg, 1970) or the gut 
fullness scale which ranged from 1-10. Verbal instructions were given prior to 
testing. 
2.2.7. Physiological measures 
Capillary blood samples were collected and analysed for the 
concentration of lactate accumulated throughout the modified LIST. A capillary 
blood sample was taken from the fingertip using a portable blood lactate 
analyser (Lactate Pro; Arkray, Kyoto, Japan) after the 15 minute warm up, and 
also after each 15 minute block of the LIST (Figure 2.2).  
Nude body mass was recorded after the initial fluid ingestion and 
immediately after the LIST to estimate fluid loss induced via exercise, taking 
into account the fluid consumed during exercise, using electronic scales (Seca, 
877, Germany). 
2.3. Statistical Analysis 
All hypothesis testing was conducted using the statistical packages for 
social sciences (SPSS; v. 22; SPSS Inc., Chicago, IL), with the alpha level set 
at P < 0.05. Mean and peak values over each 15 minute block of the LIST were 
used for GPS and heart rate analysis. A Two-way repeated measures analyses 
of variance (ANOVA) was used to assess the variability of the type of beverage 
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and time factors. Mauchley’s test was used to assess Sphericity and any 
violations were accounted for by the Greenhouse-Geisser statistic. Post-hoc 
paired t-tests using the Bonferroni adjustment were conducted to assess 
differences between blocks within trials. Effects sizes (d) (Cohen, 1977) were 
reported throughout by calculating the differences between the means divided 
by the standard deviation. Effect sizes (d) were quantified by the following 
criteria to help describe the practical significance of the findings: trivial < 0.2, 
small 0.2 – 0.6, moderate 0.6 – 1.2, large 1.2 – 2 and very large > 2 (Hopkins, 
2006; Highton et al., 2012). Results are presented as means ± SD. 
3. Results 
 
Modified LIST performance  
Distance covered 
A two-way repeated measures ANOVA reported a significant main effect 
between blocks (F(1.202, 10.819) = 19.367, P < 0.05), but no differences between 
trials (F(2,18) = 1.171, P > 0.05) or any significant interactions between trial x 
block (F(10,90) = 1.199, P > 0.05). Post-hoc analysis of between blocks, showed 
that distance covered was significantly lower (17.4 ± 32.0 m) in block 3 
(2049.6 ± 64.5 m) compared with block 2 (2067.1 ± 61.4 m) (t(29), 2.982, P = 
0.006, d = 0.29). It was also significantly lower (66.1 ± 99.4 m) in block 5 
(1981.2 ± 130.3 m) compared with block 4 (2047.3 ± 63.5 m) (t(29), 3.642, P = 
0.001, d = 0.63) and lower (77.6 ± 53.1 m) in block 6 (1903.7 ± 143.8 m) 
compared with block 5 (t(29), 7.997, P = 0.000, d = 0.60). (Figure 3.1). 
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Maximum sprint speed 
As expected, maximal speed changed between blocks (F(5,45) = 7.089, P 
< 0.05), however there were no significant differences between trials (F(2,18) = 
.422, P > 0.05) or an interaction effect between trial x block (F(10,90) = 1.051, P > 
0.05). Post-hoc analysis of between blocks showed that average maximum 
sprint speed for block 2 (23.50 ± 1.95 km·h-1) was performed significantly slower 
(1.03 ± 1.35 km·h-1) than block 1 (24.54 ± 1.23 km·h-1, t(29), 4.219, P = 0.000, d 
= 0.67). (Figure 3.1). 
Average speed 
A significant difference between blocks (F(1.202, 10.819) = 19.812, P < 0.05) 
was identified but no significant differences between trials (F(2,18) = .293, P > 
0.05) or any interaction effects between trial x block (F(10,90) = 1.100, P > 0.05). 
There was significant differences between blocks 1 and 2 (P = 0.000, d = 0.59), 
2 and 3 (P =0.004, d = 0.30), 4 and 5 (P = 0.000, d = 0.83) and finally blocks 5 
and 6 (P = 0.000, d = 0.60) (Figure 3.1). 
 
 
 
 
 
23 
 
1700
1750
1800
1850
1900
1950
2000
2050
2100
2150
2200
D
is
ta
nc
e 
(m
)
20
21
22
23
24
25
26
27
M
ax
im
al
 s
pe
ed
 (k
m
·h
-1
)
6.9
7.1
7.3
7.5
7.7
7.9
8.1
8.3
8.5
8.7
8.9
0‐15 15‐30 30‐45 45‐60 60‐75 75‐90
A
ve
ra
ge
 s
pe
ed
 (k
m
·h
-1
)
Time (m)
CHO CAF CHO + CAF
ᴥ 
Modified LIST performance 
Figure 3.1. Changes in A) Distance covered, B) Maximum speed, and C) Average 
running speed during each 15 min block of the modified List. †= CHO+CAF, ᴥ= CAF, 
¥= CHO. ‡= average of block across all 3 trials. Symbols denote significantly different 
from previous block. * denotes mean value significantly different from block 1. Values 
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Blood lactate and gut fullness 
There was a main effect of block for blood lactate (F(6,54) = 6.085, P < 
0.05) although no main effects were found between trials (F(2,18) = .501, P > 
0.05) or any interaction effects between trial x block (F(12,108) = 1.371, P  > 0.05). 
Post hoc analysis showed a significant difference between pre (3.1 ± 1.7 
mmol·L-1) and post block 1 (5.6 ± 2.4 mmol·L-1, t(29), -5.350, P = 0.000, d = -
1.27) values, and also a difference between post block 5 (5.1 ± 2.8 mmol·L-1) 
and post block 6 (3.5 ± 1.5 mmol·-1, t(29), 3.090, P = 0.004, d = 0.75) values. 
Several blood lactate levels were significantly elevated from baseline (P < 
0.008) (table3.1)  
ANOVA indicated significant differences between gut fullness values for 
block (F(2.718,24.464) = 4.306, P < 0.05), although there were no differences 
between trials (F(2,18) = .381, P > 0.05) or any trial x block interaction (F(12,108) = 
1.161, P > 0.05). Gut fullness post block 5 (2.9 ± 1.4) and post block 6 (2.4 ± 
1.4) were significantly different (t(29), 3.067, P = 0.005, d = 0.38). Although, 
further analysis showed that only block 5 in the CHO trial was significantly 
different from baseline (t(9) = -3.498, P = 0.007, d = 1.44) (Table 3.1). 
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Table 3.1. Average blood lactate, counter movement jumps and gut fullness 
values for each trial and block. * denotes significantly different from baseline. ¥ 
denotes mean value significantly different from previous block. Values are mean 
± SD.  
 
Assessment of neuromuscular function (CMJ) 
ANOVA indicated there was a main effect of block for counter movement 
jumps (F(6,54) = 4.268, P < 0.05) but no effect between trials (F(2,18) = .253, P > 
0.05) or an interaction effect between trial and block (F(12,108) = .965, P > 0.05). 
Further post hoc analysis using the Bonferroni adjustment showed no significant 
differences between trials, block or any interaction effect between trial x block 
(P > 0.008). (Table 3.1). 
Heart rate and RPE 
As expected heart rate values increased from baseline and analysis 
indicated a significant effect between blocks (F(1.648,14.829) = 9.753, P < 0.05) 
although not between trials (F(1.9,17.096) = .686) for CHO (181 ± 4 beats · min-1), 
Condition  Baseline  0‐15 min  15‐30 min  30‐45 min  45‐60 min  60‐75 min  75‐90 min 
    ¥    Blood lactate (mmol∙L‐1)  ¥ 
CHO  3.6 ± 1.5  6.2 ± 3.4  5.2 ± 1.4*  4.2 ± 2.3  4.6 ± 3.5  4.3 ± 3.1  3.2 ± 1.3 
CAF  3.3 ± 2.3  5.3 ± 1.9  5.3 ± 2.3  4.9 ± 1.9  6.4 ± 3.0  5.9 ± 2.9  4.1 ± 1.6 
CHO+CAF  2.5 ± 1.2  5.3 ± 1.5*  5.1 ± 1.9  5.3 ± 1.9*  5.2 ± 2.6*  5.3 ± 2.4*  3.4 ± 1.6 
  Counter movement Jumps (s) 
CHO  0.62 ± 0.048  0.629 ± 0.067  0.625 ± 0.053  0.616 ± 0.051  0.617 ± 0.058  0.615 ± 0.049  0.617 ± 0.049 
CAF  0.622 ± 0.049  0.628 ± 0.048  0.629 ± 0.046  0.616 ± 0.059  0.623 ± 0.044  0.611 ± 0.048  0.614 ± 0.056 
CHO+CAF  0.626 ± 0.054  0.631 ± 0.059  0.631 ± 0.058  0.629 ± 0.050  0.609 ± 0.053  0.618 ± 0.059  0.627 ± 0.055 
    Gut fullness (1‐10)  ¥ 
CHO  1.7 ± 0.7  2.2 ± 0.6  2.4 ± 0.7  2.4 ± 0.7  2.6 ± 0.8  2.8 ± 0.9*  2.5 ± 1.1 
CAF  2 ± 1.1  2 ± 0.9  2.9 ± 1.4  3 ± 1.5  2.9 ± 1.8  3.2 ± 1.9  2.5 ± 1.8 
CHO+CAF  2.4 ± 1.3  2.5 ± 1.1  2.8 ± 1.6  3.1 ± 1.7  2.8 ± 1.5  2.6 ± 1.3  2.3 ± 1.3 
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CAF (179 ± 2 beats · min-1), CHO+CAF (184 ± 3 beats · min-1) or any 
interaction between trial x block (F(4.234,38.107) = .520, P = > 0.05). Significant 
differences were identified between blocks 1 and 2 (P = 0.000, d = - 0.43), 4 
and 5 (P = 0.001, d = 0.42) and blocks 5 and 6 (P = 0.000, d = 0.47). 
Analysis revealed a main effect of block for RPE (F(1.645, 14.807) = 13.739, P < 
0.05), although there was no differences between trials (F(2,18) = .037) nor any 
interaction effect between trial x block (F(3.383, 30.447) = .147, P > 0.05). Post hoc 
analysis of between blocks indicated that there were differences between 
blocks 1 and 2 (P = 0.000, d = - 0.70), 2 and 3 (P = 0.000, d = - 0.46), and 
blocks 3 and 4 (P = 0.000, d = - 0.37). (Table 3.2). 
Table 3.2. Average heart rate and RPE values. * denotes significantly different 
from previous block. ¥ denotes mean value across all 3 trials is significantly 
different from previous block Expressed as means ± SD. 
 
 
 
 
 
 
 
Condition  0‐15 min  15‐30 min  30‐45 min  45‐60 min  60‐75 min  75‐90 min 
     
  
Heart rate (beats .min) 
     
CHO  180.1 ± 12.39  185.5 ± 11.11  186.1 ± 11.76  183.9 ± 13.54  179.1 ± 15.22  173.6 ± 16.34* 
CAF  179.8 ± 6.78  182 ± 7.47  182.8 ± 7.16  182.8 ± 6.49  178.4 ± 7.52  171.8 ± 7.48 
CHO+CAF  183.5 ± 10.26  188.2 ± 10.94*  187.9 ± 10.94  186.8 ± 10.42  182.5 ± 13.03  177.9 ± 14.45 
     
    
RPE (6‐20) 
  
     
CHO  13 ± 1.56  14.2 ± 1.81  15.5 ± 1.90*  16.1 ± 1.91*  15.8 ± 1.93  15.6 ± 1.96 
CAF  12.5 ± 2.59  14.4 ± .32*  15.2 ± 1.93  15.9 ± 1.91  16.2 ± 1.40  16.7 ± 1.77 
CHO+CAF  13.5 ± 1.84  14.5 ± 2.01  15.4 ± 2.27*  16.1 ± 2.18*  15.6 ± 1.65  15.9 ± 2.38 
¥¥ ¥
¥ ¥  ¥
27 
 
4
6
8
10
12
14
Walk Jog Cruise Sprint
A
ve
ra
ge
 s
pe
ed
 (k
m
.h
-1
)
Movement classifiation
CHO CAF CHO + CAF
Block 6 movement classifications (km·h-) 
Figure 3.2. Average walk, jog, cruise and sprint speeds during self-paced 
exercise (block 6 only). Values are expressed as mean ± SD. No significant 
differences between trials (F(2,18) = 2.130, P > 0.05). 
 
Sprint profile during self-paced exercise (block 6 only) 
 
ANOVA indicated that there was a significant difference between trials at 
the first sprint point (F(2,18), = 4.570, P < 0.05). Although post hoc analysis 
showed no differences between trials, values were approaching significance 
(CHO vs CAF; P = 0.035, d = 0.99), (CHO vs CHO+CAF; P = 0.512, d = -0.29), 
(CAF vs CHO+CAF; P = 0.024, d = -0.91). No differences were identified 
between the middle sprints (F(2,18), = .399, P > 0.05) or the end sprints (F(2,18), = 
.977, P > 0.05) between trials (Figure 3.3). 
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Figure 3.3. Average sprint speed profile during self-paced exercise (block 6). 
Values are mean ± SD. 
Change in body mass 
Body mass indicated a significant difference between pre and post 
measurements for all trials (F(2,18) = 4.434, P < 0.05). Although, changes in body 
mass between trials were insignificant (F(2,18) = .590, P > 0.05). (Table 3.3). 
Table 3.3. Changes in body mass (kg) during modified LIST. 
 
Environmental conditions 
There were no differences between trials for temperature (CHO, 20.1 ± 
1.91°C; CAF, 17.8 ± 0.58°C; CHO+CAF, 17.3 ± 1.73°C; P = 0.436). There was 
Condition  Pre LIST (kg)  Post LIST (kg)  (kg)  Cohen’s d 
CHO  86.02 ±  6.63  84.00 ± 6.41   2.01 ± .513  0.32 
CAF     85.03 ± 6.13     83.14 ± 6.04   1.89 ± .423  0.33 
CHO+CAF     85.27 ± 6.44     83.40 ± 6.24   1.87 ± .408  0.31 
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a significant difference between humidity levels recorded between trials (F(2,18) = 
4.725, P = 0.022), although further analysis indicated no significant differences 
(P > 0.01). 
4. Discussion 
 
4.1. Movement demands 
It was noted that participants covered more distance (149.6 ± 328.1 m) 
in the CHO+CAF trial (12234.3 ± 442.4 m) compared with both the CHO 
(12084.7 ± 498.2 m, d = 0.33) trial, and CAF (12135.9 ± 473.3 m, d = 0.23) 
trials (P > 0.05). There was an effect of time (P < 0.05) which coincides with 
previous research reporting a decline in distance covered over time during 
intermittent team based activities (Ali et al., 2014; Bangsbo, 1994; Mohr et al., 
2003; Reilly & Thomas, 1976).   
During part A for all trials, participants adopted  a ‘parabolic-shaped’ 
pacing profile which is identified by a reduced distance covered from the start 
(block 1) which then rises back up towards the end of the bout (block 4) (Abbiss 
et al., 2008). Participants may have increased their distance covered during 
block 4 as they recognised that it was there final block of prescribed pace, 
representing similar characteristics of the well documented ‘end-spurt’ 
phenomenon (De Koning et al., 2011; Waldron et al., 2014).   
During part B, participants utilised a ‘positive pacing’ profile which is 
characterised by a gradual decline in distance covered from block 4 to block 5, 
and from block 5 to block 6 (P < 0.01; Abbiss et al., 2008; Waldron et al., 2014). 
Potential reasons for the reported decline in performance are glycogen 
depletion, neuromuscular fatigue and metabolic accumulation (Abbiss and 
Laursen, 2005).   
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During block 6, although not significant (P > 0.05) participants covered 
more distance in the CHO+CAF trial as opposed to the CHO (d = 1.60) or CAF 
(d = 0.84) trials. An explanation for these findings is the potential sparing of 
muscle glycogen levels and a significant delayed impairment of the CNS 
towards the end of exercise following CHO supplementation (Patterson & Gray, 
2007; Yaspelkis, Patterson, Anderla, Ding & Ivy, 1993; Nybo, 2003), combined 
with a reduced RPE, reduced level of fatigue and enhanced exercise capacity 
(Stuart et al., 2005; Tarnopolski, 2008; Stear et al., 2010) following CAF 
supplementation.  
Overall, average speed was highest in the CHO+CAF trial (8.19 ± 0.45 
km·h-1) compared with the CHO (8.09 ± 0.50 km·h-1, d = 0.22) and CAF (8.11 ± 
0.46 km·h-1, d = 0.19) trials, which was also found by Jacobson, Febbraio, 
Arkinstall, and Hawley, (2001). Average speed followed a similar profile to 
distance covered, with speeds reducing from block 1 to block 3 but then rising 
again in block 4, just like a ‘U-shaped’ pacing profile (Figure 3.1). During blocks 
5 & 6 average speeds decreased in all 3 trials, indicating a ‘positive pacing’ 
profile. During block 6 however, there were higher average speed values 
recorded in the CHO+CAF (7.77 ± 0.56 km·h-1) trial as opposed to the CHO (d 
= 0.48) or CAF trial (d = 0.28). This is potentially down to the fact that maximum 
sprint speeds were higher following CHO+CAF supplementation.  
Average maximum sprint speed reduced from block 1 to block 6 (P < 
0.01, d = 0.80), which coincides with previous literature (Ali et al, 2014; Ali et al, 
2007; Gant et al, 2010; Highton et al, 2012). Sprint speeds throughout the LIST 
were similar between all trials (P > 0.05) although as expected there was a 
difference for time (P < 0.05), with post hoc analysis indicated block 1 being 
faster than all remaining blocks (P < 0.01; Figure 3.1).  
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During part A, average max speeds declined from block 1 (24.53 ± 0.35 
km·h-1), to 2 (23.50 ± 0.50 km·h-1), to 3 (23.18 ± 0.44 km·h-1), and finally to 
block 4 (22.91 ± 0.45 km·h-1). In the CAF trial the performance pattern 
described the ‘parabolic-shaped’ pacing profile, whereas the during the CHO, 
and CHO+CAF trials participants seemed to engage in a more ‘positive pacing’ 
profile with speeds decreasing from block 1 to block 4 (Figure 3.1). During part 
B, there were minimal changes in speed suggesting an ‘even pacing’ profile 
(Abbiss et al., 2008). However, during block 6, although not significant (P > 
0.05), participants sprinted quicker following CHO+CAF ingestion as opposed to 
CHO (d = 0.23) or CAF ingestion (d = 0.16), similar to the findings of Gant et al, 
(2010). 
One potential reason for faster sprints following CHO+CAF supplementation in 
block 6 could be explained by the slower average sprint speed expressed 
during blocks 1-5. In the CHO+CAF trial participants reduced their intensity from 
block 1-5, potentially reducing the rate of anaerobic glycolysis and sparing 
glycogen stores for the final block, enabling them to increase intensity towards 
the end of exercise, mimicking the ‘end-spurt’ phenomenon (De Koning et al., 
2011; Waldron et al., 2014). This is a typical characteristic of pacing strategies 
in team sports which are suggested to evenly distribute physical efforts in order 
to complete the exercise at the highest possible intensity whilst avoiding 
catastrophic failure. (De Koning et al., 2011; Edwards & Noakes, 2009). 
 
4.2. Physiological and perceptual measures during the modified LIST 
RPE, described as an accurate method of assessing exercise intensity 
(Impellizzeri, Rampinini, Cutts, Sassi, & Marcora, 2004), increased in a linear 
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fashion throughout the LIST. Average values between trials were similar (P > 
0.05; Table 3.2), although, during block 6, the reported RPE values were lower 
in the CHO+CAF (15.9 ± 2.4) trial as opposed to the CAF (16.7 ± 1.8, d = 0.40) 
trial. This is interesting as it is already apparent that the participants were 
sprinting faster, covering more distance and also working at a higher average 
intensity in the CHO+CAF trial. This reduced RPE yet improved exercise 
performance during the latter stages of exercise is a well-established response 
to the co-ingestion of caffeine with carbohydrate (Gant et al., 2010; Cureton et 
al., 2007; Doherty & Smith, 2005).   
Although no differences between trials for heart rate were identified (P > 
0.05) during block 6, values were higher in the CHO+CAF trial (177.9 ± 14.45) 
compared with the CHO (173.6 ± 16.34) and CAF (171.8 ± 7.48) trial. This 
suggests that although participants appeared to be working harder and 
subsequently performing better during block 6, there perception of effort was 
unchanged. This supports previous evidence indicating that CHO+CAF reduces 
perceptions of pain (Plaskett et al., 2001; Davis et al., 2001; Tarnopolski, 2008).  
Gut fullness in block 6 was significantly lower than block 5 (P = 0.007) 
suggesting gastric emptying was apparent as time progressed through the 
LIST. This suggests that the addition of CAF to a CHO drink does not negatively 
impact on an individual’s perceived gut-fullness, any more than either CHO or 
CAF supplemented individually. Although no significant differences between 
performance, physiological or perceptual measures were reported between 
trials, it is a worthwhile finding that there were no negative effects of 
supplementing CHO with CAF.  
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4.3. Limitations 
A main limitation of this study is that although analysis of movement 
classifications during block 6 was beneficial, a comparison with an alternative 
block (prescribed pace) would have been interesting. The relatively small 
sample size could have under powered the study, and subsequently prevented 
significant results. Due to time constraints food diaries were not analysed, and 
as a result pre-exercise dietary intake could have largely affected the findings of 
this study. Although drinks were closely matched for taste, colour and 
palatability, the reporting of ‘bitterness’ in some trials may have undermined any 
attempts to blind the participant to which supplement they consumed.  
4.4. Conclusion 
There were no significant differences identified in the current study between 
trials. However, the addition of CHO to CAF showed no negative effects on 
either performance, physiological or perceptual markers throughout the 
modified LIST compared to supplementing CHO or CAF individually. These 
findings do not warrant the prescription of CHO and CAF for team games 
players, as no positive effect on performance were highlighted.  However the 
findings do warrant further investigation, as there is clearly a potential ergogenic 
benefit of the co-ingestion of CHO and CAF, with no negative effects reported 
during this study.    
Future research may look to assess whether a dose response exists 
using the same study design, utilising the modified LIST, with varying doses of 
CAF supplemented (3-6 mg/kg/BM) combined with CHO.  
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Appendix 1. Participant information sheet  
 
The Effects of carbohydrate and caffeine on Self-Paced Intermittent 
Exercise 
 
You are being invited to take part in a research study. Before you decide, it is 
important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss 
it with others if you wish. Ask the researcher if there is anything that is not clear 
or if you would like more information. Take time to decide whether or not you 
wish to take part.  
Thank you for reading this. 
 
What is the purpose of the study? 
To investigate the effects of carbohydrate and caffeine ingestion upon exercise 
performance involving multiple sprints which aims to replicate the physiological 
demands of team sports such as football.  
 
Why have I been chosen? 
You have been chosen because you are a student at the University of Chester 
who fits between the ages of 18-30 and takes part in team sports. You will have 
to display adequate fitness levels for this research study through the use of a 
multi-stage shuttle run test (MSSRT). You will not be deemed eligible to take 
part if you fail to reach level 9 on the MSSRT as this was the limit suggested by 
Gabbett, (2005) that elite rugby league players should manage to reach. An 
assessment of the pre-test health questionnaire will also be taken by the 
researcher before the study can commence. 
 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you decide to take part 
you will be given this information sheet to keep and be asked to sign a consent 
form.  If you decide to take part you are still free to withdraw at any time and 
without giving a reason.  A decision to withdraw at any time, or a decision not to 
take part, will not affect your rights in any way 
 
What will happen to me if I take part? 
If you decide to take part, you will be given this information sheet to keep and 
asked to sign the consent form. A screening process will take place and verbal 
instructions will also be issued to you before the study can commence. 
Following this, you will take part in a Multi Stage Shuttle Run Test which 
involves running between 2 markers placed 20 metres apart whilst keeping in 
time with a beep produced by speakers. Following this you will be asked to 
perform three trials of a, modified Loughborough Intermittent Shuttle Test 
(LIST). The modified LIST involves 90 minutes of exercise. Part A (first 60 
minutes) includes a mixture of walking; jogging, running and maximal sprinting 
in time with an audio player, whilst part B (last 30 minutes) includes 2 blocks of 
15 minute self-paced exercise which requires participants to perform the same 
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activity patterns but at a self-selected pace. You will perform this test 3 times 
under 3 different conditions. The 3 trials will be carbohydrate alone, caffeine 
alone and carbohydrate + caffeine. A food diary will be issued on the day prior 
to testing which should be replicated before each testing visit. Throughout 
testing measurements will be taken by the researcher including capillary blood 
lactate samples, rating of perceived exertion (RPE), gut fullness, heart rate, 
sprint times and countermovement jump using a jump mat. 
 
What are the possible disadvantages and risks of taking part? 
The test lasts for 90 minutes, and also requires you to perform a MSSRT which 
is physically demanding. There is a risk of muscle soreness up to 48h after 
exercise which could affect other training regimes. You are also issued with a 
list of foods and drinks which should be avoided 48h prior to testing due to their 
high caffeine content. Some mild discomfort may occur following capillary blood 
lactate samples. A risk assessment will be carried out to minimise all potential 
risks. 
 
What are the possible benefits of taking part? 
The results of the study can be transferred into your preparation for training and 
competition, which can enhance an individual’s performance through the use of 
nutritional interventions. The MSSRT can inform the individuals what level of 
fitness they are at compared with others (Elite Performers).   
 
What if something goes wrong? 
If you wish to complain or have any concerns about any aspect of the way you 
have been approached or treated during the course of this study, please contact 
Professor Sarah Andrew, Dean of the Faculty of Life Sciences, University of 
Chester, Parkgate Road, Chester, CH1 4BJ. If you are harmed by taking part in 
this research project, there are no special compensation arrangements. If you 
are harmed due to someone’s negligence (but not otherwise), then you may 
have grounds for legal action, but you may have to pay for this.   
 
Will my taking part in the study be kept confidential? 
All information which is collected about you during the course of the research 
will be kept strictly confidential so that only the researcher carrying out the 
research will have access to such information.   
 
What will happen to the results of the research study? 
The results will be written up into a dissertation for my final project of my MSc. 
Individuals who participate will not be identified in any subsequent report or 
publication. 
 
Who is organising the research? 
The research is organised and conducted by a student of the Department of 
Sport and Exercise Sciences at the University of Chester 
 
Who may I contact for further information? 
If you would like more information about the research before you decide 
whether or not you would be willing to take part, please contact: 
 
Oliver Davidson 
@chester.ac.uk   Thank you for your interest in this research. 
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Appendix 2. Informed consent form 
 
 
Title of Project: Effects of Carbohydrate and Caffeine on self-paced 
intermittent exercise. 
 
Name of Researcher:  Oliver Davidson 
 
 
 
 
 
       Please initial box 
 
1. I confirm that I have read and understand the information sheet  
     for the above study and have had the opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to  
     withdraw at any time, without giving any reason and without my  
     legal rights being affected. 
 
3. I agree to take part in the above study.    
 
 
 
 
 
 
___________________                _________________   _____________ 
Name of Participant Date  Signature 
 
 
 
 
 
 
Researcher Date Signature 
 
 
 
 
 
 
47 
 
 
Appendix 3. PRE-TEST HEALTH QUESTIONNAIRE 
 
(PLEASE NOTE THAT THIS INFORMATION WILL BE CONFIDENTIAL) 
 
Name:…………………………….  DOB:…………….. Age:………… 
 
Practical/Project Title: The effects of carbohydrate and caffeine on Self-Paced 
Intermittent Exercise 
 
Please answer these questions truthfully and completely. The purpose of this 
questionnaire is to ensure that you are fit and healthy enough to participate in this 
laboratory practical/research project. 
 
Stature………….            Mass…………….. 
 
Resting Blood Pressure (measured by researcher) (mmHg)…………/………… 
 
Resting Heart Rate (measured by researcher) (b.min¯¹)……………………………. 
 
 
Yes No 
1. Have you in the past suffered from a serious illness or accident.   
If Yes, please provide details 
 
…………………………………………………………………………………………………
………………………………………………………………………………… 
 
Yes No 
2. Have you consulted your doctor the last 6 months      
If Yes, please provide details 
……………………………………………………………………………………………………
……………………………………………………………………………………………………
………………………… 
 
3. Do you suffer, or have you suffered from: 
Yes No 
Asthma        
Diabetes        
Bronchitis        
Epilepsy        
High blood pressure       
 
Yes No 
4. Is there any history of heart disease in your family        
 
Yes No 
5. Are you suffering from any infectious skin diseases, sores,        
cuts, or infections i.e., Hepatitis B, HIV, etc.?                   
If Yes, please provide brief details 
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…………………………………………………………………………………………………
…………………………………………………………………………………………… 
 
Yes No 
6. Are you currently taking any medication          
If Yes, please provide details 
 
…………………………………………………………………………………………………
…………………………………………………………………………………………………
………………………………………………………………………………………… 
 
Yes No 
7. Are you suffering from a disease that inhibits the sweating process    
 
Yes No 
8. Is there anything to your knowledge that may prevent you from     
participating in the testing that has been outlined to you? 
If Yes, please provide details 
……………………………………………………………………………………………………
……………………………………………………………………………………………………
…………………………………………………………………………………………… 
 
Your Recent Condition 
          Yes No 
 Have you eaten in the last 2 hours?        
If Yes, please provide details 
…………………………………………………………………………………………………
…………………………………………………………………………………………… 
 
 Have you consumed alcohol in the last 24hr       
 Evaluate your diet over the last two days.  Poor Average Good  Excellent 
 Have you had any kind of illness or infection in the last 2 weeks    
 Have you exercised in the last 2 days?                                                             
   
If Yes, please describe below 
  
……………………………………………………………………………………………………
……………………………………………………………………………………………………
…………………………………………………………………………………………… 
 
Persons will not be permitted to take part in any experimental testing if they: 
 have a known history of medical disorders (i.e. hypertension, heart or lung disease) 
 have a fever, suffer from fainting or dizzy spells 
 are currently unable to train because of a joint or muscle injury 
 have had any thermoregulatory disorder 
 have gastrointestinal disorder  
 have a history of infectious diseases (i.e. HIV or Hepatitis B) 
 have, if pertinent to the study, a known history of rectal bleeding, anal fissures, 
haemorrhoids or  any other similar rectal disorder. 
 
 
My responses to the above questions are true to the best of my knowledge and I am 
assured that they will be held in the strictest confidence. 
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Name: (Participant)………………………………………… Date:…………………. 
 
Signed (Participant): ……………………………………….  
     
Name: (Researcher)………………………………………… Date:…………………. 
 
Signed (Researcher): ………………………………………. 
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Appendix	4.	Daily	Food	Diary:	Oliver	
Davidson	MSc	Dissertation	Study	
Name_____________________________ 
The following food diary should be completed on the day of testing and is 
designed to provide a comprehensive overview of your food and fluid 
intake which you will be asked to repeat on your following testing visits. In 
completing this food diary, you should aim to adhere to the following 
guidelines, using the example below as a template: 
 Record all food and fluid intake during the testing day including the 
time of ingestion 
 Provide information on how meals are prepared (i.e. fried, poached, 
grilled etc.) 
 Include ingredients which are added to foods during cooking, such 
as olive oil, salt, butter etc. 
 Provide the amount and type of food consumed in the most 
accurate way possible (i.e. 1 cup full, teaspoon etc.) 
 
Time	 Food/Drink Amount	
9	am	 Quaker porridge oats with skimmed 
milk 
50 g, ¼ pint 
	 Muller fat‐free Yogurt  1 average pot 
10	am	 Bacon sandwich (wholemeal bread) 
with ketchup 
2 rashers, 2 slices, tablespoon 
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24H	food	diary	prior	to	testing	(week	
1)	
Time	 Food/Drink Amount	
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24H	food	diary	prior	to	testing	(week	
2)	
Time	 Food/Drink Amount	
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24H	food	diary	prior	to	testing	(week	
3)	
Time	 Food/Drink Amount	
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Appendix 5. MSc Research Dissertation 
Research Title: The Effects of Carbohydrate and Caffeine on Self‐paced 
Intermittent Exercise 
Researcher: Oliver Davidson 
A list of Caffeine sources to be avoided 48 hours prior to testing 
 
 Any coffee including decaffeinated 
 Normal tea 
 Green tea 
 Iced tea  
 Soft drinks (e.g. Coca Cola, Diet Coke, Dr Pepper) 
 Energy drinks (e.g. Red Bull, Relentless, Monster) 
 Caffeine tablets 
 Caffeine powder 
 Pre‐workout formulas 
 Caffeine sports gels 
 Any type of Chocolate or foods containing chocolate (cookies, 
brownies, cakes) 
 Medication such as Lemsip and headache tablets. 
If you are unsure about any products you are consuming, the researcher 
recommends that you briefly check the food/drink packet to check if there 
is any caffeine present.  
 
Any questions about certain food/drink types or any general questions 
do not hesitate to get in touch with the researcher (Oliver Davidson). 
Oliver Davidson (Researcher) 
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Faculty of Life Sciences 
Research Ethics Committee 
 
frec@chester.ac.uk 
 
 
 
Appendix 6 
Oliver Davidson 
 
Chester 
 
 
12th August 2014 
 
 
Dear Oliver, 
 
Study title: The Effects of Carbohydrate and Caffeine on Self-paced 
Intermittent Exercise.    
FREC reference: 927/14/OD/SES 
Version number: 3 
 
Thank you for sending your application to the Faculty of Life Sciences Research Ethics 
Committee for review. 
 
I am pleased to confirm ethical approval for the above research, provided that you 
comply with the conditions set out in the attached document, and adhere to the 
processes described in your application form and supporting documentation.  
 
The final list of documents reviewed and approved by the Committee is as follows: 
 
Document                       Version Date 
Application Form                                   1 May 2014 
Appendix 1 – List of References 1 May 2014 
Appendix 2 – C.V. for Lead Researcher 1 May 2014 
Appendix 3 – Participant Information Sheet 1 May 2014 
Appendix 4 – Participant Consent Form 1 May 2014 
Appendix 5 – Risk Assessment Form 1 May 2014 
Appendix 6 – Daily Food Diary 1 May 2014 
Appendix 7 – List of caffeine sources to avoid 48 hours 
prior to testing 
1 May 2014 
Appendix 8 – Pre-test Questionnaire 1 May 2014 
Response to FREC request for further information or 
clarification 
 July 2014 
FREC Application Form 2 July 2014 
Appendix 1 – C.V. for Lead Researcher 1 July 2014 
Appendix 2 – Participant Information Sheet 2 July 2014 
Appendix 3 – Participant Consent Form 2 July 2014 
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Appendix 4 – Pre-test Health Questionnaire 2 July 2014 
Appendix 5 – Risk Assessment Form 2 July 2014 
Appendix 6 – Daily Food Diary 2 July 2014 
Appendix 7 – List of caffeine sources to avoid 48 hours 
prior to testing 
2 July 2014 
Appendix 8 – Capillary blood sampling consent form 1 July 2014 
Appendix 9 – Recovery Protocol 1 July 2014 
Appendix 10 – List of References 2 July 2014 
Response to FREC request for further information or 
clarification 
 August 2014 
FREC Application Form 3 August 2014 
Appendix 1 – C.V. for Lead Researcher 1 August 2014 
Appendix 2 – Participant Information Sheet 3 August 2014 
Appendix 3 – Participant Consent Form 2  
Appendix 4 – Pre-test Health Questionnaire 3 August 2014 
Appendix 5 – Risk Assessment Form 2 August 2014 
Appendix 6 – Daily Food Diary 2  
Appendix 7 – List of caffeine sources to be avoided 48 
hours prior to testing 
3 August 2014 
Appendix 9 – Recovery Protocol 1 August 2014 
Appendix 10 – Letter of Invitation 1 August 2014 
Response to FREC request for further justification  August 2014 
 
 
Please note that this approval is given in accordance with the requirements of English 
law only. For research taking place wholly or partly within other jurisdictions (including 
Wales, Scotland and Northern Ireland), you should seek further advice from the 
Committee Chair / Secretary or the Research and Knowledge Transfer Office and may 
need additional approval from the appropriate agencies in the country (or countries) in 
which the research will take place. 
 
With the Committee’s best wishes for the success of this project.  
 
Yours sincerely, 
 
 
 
 
 
Dr. Stephen Fallows 
Chair, Faculty Research Ethics Committee 
 
Enclosures: Standard conditions of approval.   
 
Cc. Supervisor/FREC Representative 
 
 
 
 
